WEBSITECHANGES

Website Changes

---

01/09/2020

Survival analysis of patients with glioblastoma treated by long-term administration of temozolomide.

---

01/08/2020

New book takes a humorous look at brain cancer

---

01/08/2020

Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma.

---

01/07/2020

DIPG Advocacy Group Announces Congressional Briefing for Pediatric Brain Cancer

---

01/06/2020

Musella Foundation Awards $250,000 Brain Tumor Research Grant

---

01/05/2020

Mount Sinai Receives More Than $10 Million in Grant Funding for Brain Tumor Research

---

01/04/2020

Regorafenib in glioblastoma recurrence: how to deal with conflicting ‘real-life’ experiences?

---

01/04/2020

Cost-effectiveness analysis of the addition of bevacizumab to temozolomide therapy for the treatment of unresected glioblastoma.

---

01/04/2020

Complete radiological response following subtotal resection in three glioblastoma patients under treatment with Tumor Treating Fields.

---

12/28/2019

Made website more accessable! Click the logo on top right of any page to see!

---

12/25/2019

A randomized controlled phase III study of VB-111 combined with bevacizumab vs. bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE).

---

12/25/2019

Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastoma.

---

12/25/2019

Safety and efficacy of VB-111, an anti-cancer gene-therapy, in patients with recurrent glioblastoma: results of a phase I/II study

---

12/16/2019

Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma.

---

12/03/2019

Musella Foundation`s Annual Giving Campaign

---

12/03/2019

SNO 2019: The Oncolytic Herpes Virus G47? May Lead to a Potential Cure of Malignant Glioma

---

12/01/2019

New Italian version of our Brain Tumor Guide for the Newly Diagnosed!

---

11/28/2019

New videos added to Virtualtrials.com

---

11/25/2019

SNO 2019: The Oncolytic Herpes Virus G47? May Lead to a Potential Cure of Malignant Glioma

---

11/25/2019

DNAtrix Presents Positive Results from the Phase 2 CAPTIVE/KEYNOTE-192 Study of DNX-2401 in Combination with Pembrolizumab for Glioblastoma at the 2019 SNO Annual Meeting

---

11/25/2019

Novocure Announces 43 Presentations on Tumor Treating Fields at 24th Annual Meeting of the Society for Neuro-Oncology

---

11/25/2019

Val-083 for unmethylated GBM

---

11/25/2019

The Conversation

---

11/19/2019

Publication in Nature Communications Confirms DRD2 as Target of ONC201

---

11/19/2019

RESULTS OF PHASE II CLINICAL TRIAL OF ONCOLYTIC HERPES VIRUS G47? IN PATIENTS WITH GLIOBLASTOMA

---